Partnering for Cancer Care: Understanding Germline Genetic Testing
A new video resource for consumers has been developed to support existing materials within the Cancer Germline Genetic Testing toolkit.
Read the full storyGermline testing provides important information to guide treatment decisions in cancer care. The use of germline testing in cancer care has expanded rapidly in recent years, partly due to the growth in knowledge and technology around genetic testing, including new treatment options available based on genetic testing results and an expansion in eligibility criteria for germline testing.
To support a streamlined and consistent pathway for patients accessing germline testing, the Cancer Statewide Clinical Network (CSCN) identified the need for a co-developed statewide framework. The development of the framework was guided by a multi-disciplinary working group, including representation from SA Pathology, Adelaide Genetics Unit (AGU), Local Health Networks (LHN) and consumers.
The working group, led by Dr Eryn Dow Clinical Cancer Geneticist from AGU, undertook consultation with relevant stakeholders across all SA LHNs which informed a comprehensive review of the current germline testing practice and pathways across LHNs.
Enhancing Mainstream Germline Genetic Testing Support
Healthcare workers play a vital role in ensuring patients have access to comprehensive information about their healthcare options. To support the framework, we have developed resources to further support those undergoing Mainstream Germline Genetic Testing for Cancer.
Streamlined Patient Education:
To support the framework, mainstream genetic packs are available on the Adult Genetics Unit website for clinicians across the health system to support mainstream germline testing. These packs include information sheets, flowcharts, consent forms, testing criteria, guides, consent forms and partially filled pathology request forms.
Empowering Informed Decisions:
An informative video has also been developed, specifically designed for patients after their consultation with a cancer specialist. It offers clear and concise information about genetic testing, allowing patients to learn more at their own pace and ask informed questions during their appointments.
The Patient Information Sheet included in the packs is in the process of being updated to include a link to the video. Healthcare professionals. Healthcare professionals can also share this link directly with patients. This empowers patients to participate actively in their healthcare journey and make informed decisions about their testing options.
Working Together:
By utilising the Mainstream Germline Genetic Testing Packs and the informative video, healthcare professionals can ensure their patients have access to the information they need throughout their cancer care journey.
Evaluation of the framework is underway, to measure effectiveness in terms of implementation, utility and outcomes. Consumer experience and satisfaction with the mainstreaming process will also be captured.
We would like to thank SA Pathology for their contribution toward the project to enable high level high level data oversight and enable the evaluation and monitoring of mainstreaming germline testing rates.